No Record Found
Sector
PharmaceuticalsOpen
₹9.75Prev. Close
₹0Turnover(Lac.)
₹7.47Day's High
₹9.8Day's Low
₹9.752 Week's High
₹052 Week's Low
₹0Book Value
₹1.81Face Value
₹2Mkt Cap (₹ Cr.)
81.26P/E
0EPS
0Divi. Yield
0No Record Found
| Y/e 31 Mar( In .Cr) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | 
|---|---|---|---|---|
| Equity Capital | 16.58 | 16.58 | 16.58 | 16.58 | 
| Preference Capital | 0 | 0 | 0 | 0 | 
| Reserves | 41.91 | 72.83 | 116.73 | 440.69 | 
| Net Worth | 58.49 | 89.41 | 133.31 | 457.27 | 
| Minority Interest | 
| Y/e 31 Mar( In .Cr) | Mar-2020 | Mar-2018 | Mar-2017 | Mar-2016 | 
|---|---|---|---|---|
| Revenue | 276.6 | 261.38 | 569.83 | 319.39 | 
| yoy growth (%) | 5.82 | -54.12 | 78.41 | -25.74 | 
| Raw materials | -150.3 | -86.4 | -179.93 | -131.54 | 
| As % of sales | 54.33 | 33.05 | 31.57 | 41.18 | 
| Employee costs | -31.86 | -34.08 | -42.23 | -23.99 | 
| Y/e 31 Mar( In .Cr) | Mar-2020 | Mar-2018 | Mar-2017 | Mar-2016 | 
|---|---|---|---|---|
| Profit before tax | -20.74 | 8.85 | 173.38 | 11.34 | 
| Depreciation | -16.56 | -18.14 | -26.83 | -18.79 | 
| Tax paid | 1.57 | 1.01 | -47.04 | -3.21 | 
| Working capital | -97.43 | -74.68 | -7.35 | 108.09 | 
| Other operating items | 
| Y/e 31 Mar | Mar-2020 | Mar-2018 | Mar-2017 | Mar-2016 | 
|---|---|---|---|---|
| Growth matrix (%) | ||||
| Revenue growth | 5.82 | -54.12 | 78.41 | -25.74 | 
| Op profit growth | -57.98 | -69.29 | 193.76 | -19.39 | 
| EBIT growth | -63.3 | -73.88 | 244.54 | -22.16 | 
| Net profit growth | -294.28 | -92.19 | 1,454.62 | -57.07 | 
| Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 | 
|---|---|---|---|---|---|
| Gross Sales | 116.27 | 149.07 | 187.1 | 237.29 | 861.47 | 
| Excise Duty | 0 | 0 | 0 | 0 | 0 | 
| Net Sales | 116.27 | 149.07 | 187.1 | 237.29 | 861.47 | 
| Other Operating Income | 0 | 0 | 0 | 0 | 0 | 
| Other Income | 4.37 | 9.98 | 0.97 | 1.27 | 9.82 | 
| Company Name | LTP (₹) | P/E  (%) | Mkt.Cap  (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield  (%) | Sales Qtr  (₹.Cr) | Book Value (₹) | 
|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,703.4 | 82.06 | 4,08,750.71 | 753.53 | 0.94 | 5,566.68 | 101.44 | 
| Divis Laboratories Ltd DIVISLAB | 6,655 | 75.61 | 1,76,633.5 | 557 | 0.45 | 2,357 | 561.08 | 
| Cipla Ltd CIPLA | 1,540.1 | 23.94 | 1,24,437.16 | 1,210.53 | 1.04 | 4,495.16 | 411.56 | 
| Torrent Pharmaceuticals Ltd TORNTPHARM | 3,602.4 | 61.3 | 1,21,865.35 | 551 | 0.17 | 2,567 | 224.34 | 
| Mankind Pharma Ltd MANKIND | 2,446.6 | 55.79 | 1,00,950.41 | 412.76 | 0 | 2,541.36 | 354.69 | 
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Managing Director & Chief Executive Officer
Santosh Varalwar
Whole-time Director
Subhash Varalwar
Whole-time Director
V Manohar Rao
Independent Director
M Bhagavantha Rao
Whole-time Director
Sandeep Varalwar
Whole Time Director & Chief Financial Officer
S Raghunandan
Independent Director
V Peesapati
Company Secretary
Yugandhar Kopparthi
Additional Director
Aparna Bidarkar
Plot No 78-A,
Kolhar Industrial Area,
Karnataka - 585403
Tel: 91-8482-232045
Website: http://www.vivimedlabs.com
Email: yugandhar.kopparthi@vivimedlabs.com
1-2-285 Domalguda,
Hyderabad - 500 029
Tel: 91-040-27638111/4445
Website: www.aarthiconsultants.com
Email: info@aarthiconsultants.com
Summary
Vivimed Labs Limited was originally incorporated on September 22, 1988 as a private limited company in the name of Emgi Pharmaceuticals & Chemicals Pvt Ltd. On April 21, 1994, the company got converte...
Read More
Reports by Vivimed Labs Ltd








 IIFL Customer Care Number
 IIFL Customer Care Number 
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000  / 7039-050-000
 IIFL Capital Services Support WhatsApp Number
 IIFL Capital Services Support WhatsApp Number
+91 9892691696


IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.